Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders DOI
Monica Bettina Elkjær Greenwood Ormerod, Thor Ueland, Monica Aas

et al.

Acta Neuropsychiatrica, Journal Year: 2025, Volume and Issue: 37

Published: Jan. 1, 2025

Abstract Objective: Accelerated ageing indexed by telomere attrition is suggested in schizophrenia spectrum- (SCZ) and bipolar disorders (BD). While inflammation may promote shortening, few studies have investigated the association between length (TL) markers of immune activation severe mental disorders. Methods: Leucocyte TL defined as template/amount single-copy gene template (T/S ratio), was determined participants with SCZ ( N = 301) or BD 211) a healthy control group (HC, 378). analysed linear regressions for associations levels 12 linked to BD. Adjustments were made broad range potential confounding variables. measured quantitative polymerase chain reaction (qPCR) enzyme immunoassays. Results: A positive soluble tumour necrosis factor receptor 1A (sTNF-R1) β 0.191, p 0.012) observed. Plasma other not significantly associated BD, HC groups. Conclusion: There limited evidence The results provide little support involvement dysregulation, reflected current systemic markers, attrition-related accelerated

Language: Английский

Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia DOI
Błażej Misiak, Edyta Pawlak,

Krzysztof P. Rembacz

et al.

Journal of Psychiatric Research, Journal Year: 2024, Volume and Issue: 171, P. 152 - 160

Published: Jan. 23, 2024

Language: Английский

Citations

26

Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants DOI Creative Commons
Nicola Warren, Cullen O’Gorman,

Isabelle Horgan

et al.

Schizophrenia Research, Journal Year: 2024, Volume and Issue: 266, P. 24 - 31

Published: Feb. 15, 2024

There is increasing evidence of immune dysregulation and neuroinflammation occurring in schizophrenia. The aim this study to combine studies on routine CSF parameters, as well cytokines inflammatory proteins, individuals with schizophrenia spectrum disorders.

Language: Английский

Citations

14

Microglia-neuron interactions in schizophrenia DOI Creative Commons
Sophia-Marie Hartmann, Johanna Heider,

Richard Wüst

et al.

Frontiers in Cellular Neuroscience, Journal Year: 2024, Volume and Issue: 18

Published: March 6, 2024

Multiple lines of evidence implicate increased neuroinflammation mediated by glial cells to play a key role in neurodevelopmental disorders such as schizophrenia. Microglia, which are the primary innate immune brain, crucial for refinement synaptic circuitry during early brain development pruning and regulation plasticity adulthood. Schizophrenia risk factors genetics or environmental influences may further be linked activation microglia, an increase pro-inflammatory cytokine levels inflammasome resulting overall elevated neuroinflammatory state patients. Synaptic loss, one central pathological hallmarks schizophrenia, is believed due excess removal synapses activated primarily affecting glutamatergic neurons. Therefore, it investigate microglia-neuron interactions, has been done multiple studies focusing on post-mortem tissues, imaging, animal models patient iPSC-derived 2D culture systems. In this review, we summarize major findings patients vivo vitro context neuron-microglia interactions schizophrenia secondly discuss potential anti-inflammatory treatments alleviation positive, negative, cognitive symptoms.

Language: Английский

Citations

13

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder? DOI Creative Commons
Song Chen, Yunlong Tan, Li Tian

et al.

Molecular Psychiatry, Journal Year: 2024, Volume and Issue: 29(9), P. 2834 - 2848

Published: March 26, 2024

Immunopsychiatric field has rapidly accumulated evidence demonstrating the involvement of both innate and adaptive immune components in psychotic disorders such as schizophrenia. Nevertheless, researchers are facing dilemmas discrepant findings immunophenotypes outside inside brains patients, discovered by recent meta-analyses. These discrepancies make interpretations interrogations on their roles psychosis remain vague even controversial, regarding whether certain cells more activated or less so, they causal consequential, beneficial harmful for psychosis. Addressing these issues is not at all trivial, either brain an enormously heterogeneous plastic cell population, falling into a vast range lineages subgroups, functioning differently malleably context-dependent manners. This review aims to overview currently known patients with psychosis, provocatively suggest premature "burnout" inflamm-aging initiated since organ development potential primary mechanism behind pathogenesis disorders.

Language: Английский

Citations

9

Immune Dysfunction in Schizophrenia Spectrum Disorders DOI
Shiral S. Gangadin, Anne-Sophie D. Enthoven,

Nico J.M. van Beveren

et al.

Annual Review of Clinical Psychology, Journal Year: 2024, Volume and Issue: 20(1), P. 229 - 257

Published: July 12, 2024

Evidence from epidemiological, clinical, and biological research resulted in the immune hypothesis: hypothesis that system dysfunction is involved pathophysiology of schizophrenia spectrum disorders (SSD). The promising implication this potential to use existing immunomodulatory treatment for innovative interventions SSD. Here, we provide a selective historical review important discoveries have shaped our understanding We first explain basic principles dysfunction, after which travel more than century back time. Starting journey with neurosyphilis-associated psychosis nineteenth century, continue by evaluating role infections autoimmunity SSD findings assessment function using new techniques, such as cytokine levels, microglia density, neuroimaging, gene expression. Drawing these findings, discuss anti-inflammatory SSD, conclude look into future.

Language: Английский

Citations

8

Neurotrophin-3 as a mediator in the link between PM2.5 exposure and psychiatric disorders: A Mendelian randomization study DOI Creative Commons
Yuan Zhang, Wei Wang, Xuening Zhang

et al.

Ecotoxicology and Environmental Safety, Journal Year: 2025, Volume and Issue: 289, P. 117658 - 117658

Published: Jan. 1, 2025

The causal relationship between PM2.5 (particulate matter with an aerodynamic diameter ≤2.5 μm) and common mental disorders, along its neuropathological mechanisms, remains unclear. We used genome-wide association study datasets from the UK Biobank Psychiatric Genomics Consortium to systematically investigate nine psychiatric disorders using two-sample Mendelian randomization (TSMR) methods. Subsequently, we two-step MR mediating effect of 108 potential mediators in disorders. Our findings indicated that was positively associated major depressive disorder (odds ratio (OR): 1.33, 95 % confidence interval (CI): 1.11-1.55), anxiety (OR: 2.96, CI: 2.13-3.79), schizophrenia 1.55, 1.29-1.81), attention deficit hyperactivity (ADHD) 1.95, 1.66-2.24). Unexpectedly, inversely bipolar 0.65, 0.37-0.93). Additionally, not significantly autism spectrum 1.24, 0.83-1.65), post-traumatic stress 1.51, 1.11-1.91), obsessive-compulsive 0.81, -0.07-1.69), or anorexia nervosa 1.42, 0.86-1.98). Further analysis revealed Neurotrophin-3 mediated 9.86 PM2.5-ADHD 5.88 PM2.5-schizophrenia association. Sensitivity analyses supported these findings. This TSMR provides a comprehensive examination exposure mediation offering insight into underlying mechanisms. aims raise public awareness how air quality affects health through empirical evidence.

Language: Английский

Citations

1

Potential Benefits of Ketone Therapy as a Novel Immunometabolic Treatment for Schizophrenia DOI
Karin Huizer, Shubham Soni,

M. Schmidt

et al.

Psychiatry Research, Journal Year: 2025, Volume and Issue: 345, P. 116379 - 116379

Published: Jan. 29, 2025

Language: Английский

Citations

1

The gut microbiota-immune-brain axis: Therapeutic implications DOI Creative Commons
Kenneth J. O’Riordan, Gerard M. Moloney, Lily Keane

et al.

Cell Reports Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 101982 - 101982

Published: March 1, 2025

Language: Английский

Citations

1

Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data DOI Creative Commons
Evgeny A. Ermakov, Mark M. Melamud, Anastasiia S. Boiko

et al.

Brain Sciences, Journal Year: 2023, Volume and Issue: 13(5), P. 836 - 836

Published: May 22, 2023

Multiple lines of evidence are known to confirm the pro-inflammatory state some patients with schizophrenia and involvement inflammatory mechanisms in pathogenesis psychosis. The concentration peripheral biomarkers is associated severity inflammation can be used for patient stratification. Here, we analyzed changes serum concentrations cytokines (IL-1β, IL-2, IL-4, IL-6, IL-10, IL-21, APRIL, BAFF, PBEF/Visfatin, IFN-α, TNF-α) growth/neurotrophic factors (GM-CSF, NRG1-β1, NGF-β, GDNF) an exacerbation phase. IL-1β, GM-CSF, GDNF increased but TNF-α NGF-β decreased compared healthy individuals. Subgroup analysis revealed effect sex, prevalent symptoms, type antipsychotic therapy on biomarker levels. Females, predominantly negative those taking atypical antipsychotics had a more phenotype. Using cluster analysis, classified participants into "high" "low inflammation" subgroups. However, no differences were found clinical data these Nevertheless, (17% 25.5%) than donors (8.6% 14.3%) condition depending clustering approach used. Such may benefit from personalized anti-inflammatory therapy.

Language: Английский

Citations

17

Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain DOI Creative Commons
Linn Sofie Sæther, Attila Szabó, Ibrahim A. Akkouh

et al.

Brain Behavior and Immunity, Journal Year: 2024, Volume and Issue: 118, P. 287 - 299

Published: March 8, 2024

Recent findings link cognitive impairment and inflammatory-immune dysregulation in schizophrenia (SZ) bipolar (BD) spectrum disorders. However, heterogeneity translation between the periphery central (blood-to-brain) mechanisms remains a challenge. Starting with large SZ, BD healthy control cohort (n = 1235), we aimed to i) identify candidate peripheral markers 25) associated domains 9) elucidate heterogenous immune-cognitive patterns, ii) evaluate regulation of using human induced pluripotent stem cell (iPSC)-derived astrocytes neural progenitor cells 10), iii) marker messenger RNA expression leukocytes microarray available data from subsample main 776), RNA-sequencing deconvolution analysis postmortem brain samples 474) CommonMind Consortium (CMC). We identified transdiagnostic subgroups based on covariance (measures speed verbal learning) reflecting inflammatory response (CRP, sTNFR1, YKL-40), innate immune activation (MIF) extracellular matrix remodelling (YKL-40, CatS). Of there was considerable variance secretion YKL-40 iPSC-derived SZ compared HC. Further, provide evidence dysregulated genes encoding related signalling pathways high neuroinflammatory subgroup samples. Our suggest relationship activity impairment, highlight as potential functioning individuals severe mental illness.

Language: Английский

Citations

7